Discovery of novel and potent 2-aminopyrazine-based HPK1 inhibitors enhancing T-cell immunity against cancer
Fields of Study & Subjects
Melanoma and MAPK Pathways
NF-κB Signaling Pathways
Protein Tyrosine Phosphatases
Publication details
- Journal / source
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Volume
- 308
- Pages
- 118689–118689
- Publication date
- 18 February 2026
- Language
- EN